Cargando…

Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic Review

Patients suffering from Fabry disease (FD) have an increased risk of developing neuropsychiatric symptoms (NPS), mostly impairment in cognitive performance and depression. Single cases of psychosis have been reported, however, their association with FD can be coincidental. Furthermore, deficits in s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mroczek, Magdalena, Maniscalco, Ignazio, Sendel, Manon, Baron, Ralf, Seifritz, Erich, Nowak, Albina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967288/ https://www.ncbi.nlm.nih.gov/pubmed/35370863 http://dx.doi.org/10.3389/fpsyt.2022.829128

Ejemplares similares

Stratification of patients with unclassified pain in the FabryScan database
por: Forstenpointner, Julia, et al.
Publicado: (2019)

Bridging the Gap Between Vessels and Nerves in Fabry Disease
por: Forstenpointner, Julia, et al.
Publicado: (2020)

Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy
por: Franzen, Daniel, et al.
Publicado: (2018)

Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer’s Dementia: A Clinical Case Report
por: Defrancesco, Michaela, et al.
Publicado: (2020)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Loss Aversion and Risk Aversion in Non-Clinical Negative Symptoms and Hypomania
por: Klaus, Federica, et al.
Publicado: (2020)

Commentary: Antidepressant Use During Acute Inpatient Care is Associated With an Increased Risk of Psychiatric Rehospitalisation Over a 12-Month Follow-Up after Discharge
por: Seifritz, Erich
Publicado: (2020)

Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms
por: Gostner, Johanna M., et al.
Publicado: (2015)

SPECT findings on neuropsychiatric symptoms caused by nitrous oxide abuse
por: Wang, Li, et al.
Publicado: (2022)

Psychopathological Symptom Load and Distinguishable Cerebral Blood Flow Velocity Patterns in Patients With Schizophrenia and Healthy Controls: A Functional Transcranial Doppler Study
por: Egger, Stephan T., et al.
Publicado: (2021)

Anosognosia in Early- and Late-Onset Dementia and Its Association With Neuropsychiatric Symptoms
por: Tondelli, Manuela, et al.
Publicado: (2021)

Neuropsychiatric Symptoms Exacerbate the Cognitive Impairments in Patients With Late-Life Depression
por: Zhang, Min, et al.
Publicado: (2021)

Neuropsychiatric symptoms and altered sleep quality in cerebral small vessel disease
por: Li, Xi, et al.
Publicado: (2022)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
por: Bergamini, Giorgio, et al.
Publicado: (2022)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery
por: Cross, Amy, et al.
Publicado: (2021)

A Case of Neuropsychiatric Systemic Lupus Erythematosus With Hair Loss as the First Diagnostic Symptom
por: He, Xun, et al.
Publicado: (2022)

Fabry disease in children and the effects of enzyme replacement treatment
por: Pintos-Morell, Guillem, et al.
Publicado: (2009)

Cost-effectiveness of enzyme replacement therapy for Fabry disease
por: Rombach, Saskia M, et al.
Publicado: (2013)

Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity
por: Vonmoos, Matthias, et al.
Publicado: (2019)

Neuropsychiatric Symptoms in Elderly With Dementia During COVID-19 Pandemic: Definition, Treatment, and Future Directions
por: Simonetti, Alessio, et al.
Publicado: (2020)

Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits
por: Wiels, Wietse A., et al.
Publicado: (2021)

Crowd-sourced investigation of a potential relationship between Bartonella-associated cutaneous lesions and neuropsychiatric symptoms
por: Stewart, Zachary, et al.
Publicado: (2023)

Neuroimaging Correlates of Resilience to Traumatic Events—A Comprehensive Review
por: Bolsinger, Julia, et al.
Publicado: (2018)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry Disease
por: Lelieveld, Irene M., et al.
Publicado: (2015)

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease
por: Fervenza, Fernando C, et al.
Publicado: (2008)

Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease
por: Moore, David F, et al.
Publicado: (2002)

Long-Term Effect of Enzyme Replacement Therapy with Fabry Disease
por: Komori, Manabu, et al.
Publicado: (2013)

Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
por: Hansen, Niels, et al.
Publicado: (2020)

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
por: Mroczek, Magdalena, et al.
Publicado: (2022)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Utilization and Effectiveness of Home Treatment for People With Acute Severe Mental Illness: A Propensity-Score Matching Analysis of 19 Months of Observation
por: Mötteli, Sonja, et al.
Publicado: (2018)

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study
por: Levada, Oleg A., et al.
Publicado: (2017)

Probing the relevance of the accelerated aging mouse line SAMP8 as a model for certain types of neuropsychiatric symptoms in dementia
por: Bergamini, Giorgio, et al.
Publicado: (2023)

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis
por: Beck, Michael, et al.
Publicado: (2015)

Gender Differences in the Application of Spanish Criteria for Initiation of Enzyme Replacement Therapy for Fabry Disease in the Fabry Outcome Survey
por: Barba-Romero, Miguel-Ángel, et al.
Publicado: (2016)

Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease
por: Kim, Il Young, et al.
Publicado: (2021)

The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review
por: Manca, Riccardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_90t3jdg9h4obsufovn4b20v9qo